CN105748697A - 一种中药组合物在用于制备外感风热药物方面的新用途 - Google Patents
一种中药组合物在用于制备外感风热药物方面的新用途 Download PDFInfo
- Publication number
- CN105748697A CN105748697A CN201610098788.3A CN201610098788A CN105748697A CN 105748697 A CN105748697 A CN 105748697A CN 201610098788 A CN201610098788 A CN 201610098788A CN 105748697 A CN105748697 A CN 105748697A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- active component
- medical material
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 201000009240 nasopharyngitis Diseases 0.000 title abstract description 10
- 239000012567 medical material Substances 0.000 claims abstract description 25
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 29
- 238000000605 extraction Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 244000110343 Elephantopus scaber Species 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 235000008597 Diospyros kaki Nutrition 0.000 claims description 7
- -1 filters Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 7
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 3
- 201000007100 Pharyngitis Diseases 0.000 abstract description 3
- 240000005589 Calophyllum inophyllum Species 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000011511 Diospyros Nutrition 0.000 abstract 1
- 244000062189 Picria fel-terrae Species 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 240000008488 Thlaspi arvense Species 0.000 abstract 1
- 235000008214 Thlaspi arvense Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 15
- 239000002775 capsule Substances 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 208000004145 Endometritis Diseases 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- QLDAACVSUMUMOR-UHFFFAOYSA-M 2,3-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium;chloride Chemical compound [Cl-].C1=C2C3=[N+](C)C=C4C=C(OC)C(OC)=CC4=C3C=CC2=CC2=C1OCO2 QLDAACVSUMUMOR-UHFFFAOYSA-M 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 241000245240 Lonicera Species 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 206010039101 Rhinorrhoea Diseases 0.000 description 2
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 208000010753 nasal discharge Diseases 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000005182 tip of the tongue Anatomy 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010004054 Bacterial upper respiratory tract infections Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000546193 Clusiaceae Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000792913 Ebenaceae Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000016908 Female Genital disease Diseases 0.000 description 1
- 244000173782 Ficus hirta Species 0.000 description 1
- 108010010803 Gelatin Chemical class 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000800405 Spatholobus suberectus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047482 Viral upper respiratory tract infection Diseases 0.000 description 1
- 240000003248 Zanthoxylum nitidum Species 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229920000159 gelatin Chemical class 0.000 description 1
- 239000008273 gelatin Chemical class 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/44—Ebenaceae (Ebony family), e.g. persimmon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种中药组合物在制备治疗风热感冒、咽喉肿痛药物方面的新用途。该中药组合物是由:苦玄参、地胆草、当归、鸡血藤、两面针、横经席、柿叶、菥蓂、五指毛桃等药材为原料制备而成的。本发明提供的中药组合物具有改善外感风热、咽喉肿痛症状的作用。
Description
技术领域
本发明涉及中药技术领域,具体涉及一种中药组合物在用于制备外感风热药物方面的新用途。
技术背景
风热感冒是风热之邪犯表、肺气失和所致。症状表现为发热重、微恶风、头胀痛、有汗、咽喉红肿疼痛(扁桃体炎)、咳嗽、痰粘或黄、鼻塞黄涕、口渴喜饮、舌尖边红、苔薄白微黄。治法应以辛凉解表为主。从现代医学角度解释,即由病毒或细菌引起的上呼吸道感染,治疗当以抑菌杀菌消炎为主。
妇炎净为《中华人民共和国药典》2010年版公开的复方,在药典中公开了妇炎净胶囊的如下信息:
1)组成:苦玄参、地胆草、当归、鸡血藤、两面针、横经席、柿叶、菥蓂、五指毛桃;
2)制法:以上九味,取部分苦玄参,粉碎成细粉;剩余苦玄参与其余地胆草等八味加水煎煮二次,第一次3小时,第二次2小时,煎液滤过,滤液合并,浓缩至适量,与上述细粉混匀,干燥,粉碎,装入胶囊,制成1000粒。
3)功能与主治:清热祛湿,调经止带。用于湿热蕴结所致的带下病,月经不调、痛经;慢性盆腔炎、附件炎、子宫内膜炎等见上述证候者。
关于妇炎净的提取及分析方法有以下报道:
中国专利申请200510200230.3明确了妇炎净的制备方法中:50%的苦玄参粉碎,其余水煎煮两次的制备方法。
中国专利申请200410060988.7公开了由苦玄参、地胆草、当归、横经席、柿叶、菥蓂、五指毛桃、鸡血藤、两面针制成的中药复方制剂,该专利公开的制备方法采用全部药材水提,或水提后醇沉。
中国专利申请201110437435.9公开了一种妇炎净口服制剂及其制备方法,公开的制备方法为部分苦玄参粉碎,剩余苦玄参与其余八位药材水提,配伍聚乙二醇实现成分增溶。
中国专利申请201210548084公开了一种治疗妇科炎症的中药组合物及其制备方法,该专利原料为妇炎净原料,公开的制备方法采用全部药材醇提两次。
中国专利申请201010161033公开了一种治疗女性生殖系统炎症的药物及其制备和质量控制方法,该专利使用是原料为妇炎净原料,公开的制备方法为为部分苦玄参粉碎,剩余苦玄参与其余八味药材水提,公开了制剂中氯化两面针碱的检测方法。
中国专利申请200910136264.9公开了一种妇炎净片的分析方法,公开的分析方法检测制剂中氯化两面针碱。
中国专利申请200510200357公开了一种中药组合物及其制备方法和质量控制方法,该专利公开了由苦玄参、地胆草、当归、横经席、柿叶、菥蓂、五指毛桃、鸡血藤、两面针制成的中药组合物,公开的制备方法为部分苦玄参粉碎,剩余苦玄参与其余八位药材水提,公开了制剂中阿魏酸的检测方法。
目前未检索到妇炎净处方可用于治疗风热感冒、咽喉肿痛方面的文献报道。
发明内容
本发明的目的是提供一种中药组合物在用于制备外感风热药物方面的新用途。
本发明的目的是通过下列的技术方案实现的:
本发明所述的中药组合物,是由含以下重量份的原料制备而成的:
苦玄参350份、地胆草350份、菥蓂300份、柿叶200份、五指毛桃200份、当归150份、鸡血藤150份、两面针150份、横经席150份。
本发明药材来源:
苦玄参:本品为玄参科植物苦玄参Picriafel‐terraeLour.的干燥全草。秋季采收,除去杂质,晒干。【性味】苦,寒。【归经】归肺、胃、肝经。【功能主治】清热解毒,消肿止痛。用于风热感冒,咽喉肿痛,喉痹,痄腮,脘腹疼痛,痢疾,跌打损伤,疖肿,毒蛇咬伤。
地胆草:本品为菊科地胆草属植物地胆草ElephantopusscaberL.,以全草入药。夏秋采收,去杂质,洗净晒干或鲜用。【性味】苦,凉。【归经】肝、胆经【功能主治】清热解毒,利尿消肿。用于感冒,急性扁桃体炎,咽喉炎,眼结膜炎,流行性乙型脑炎,百日咳,急性黄疸型肝炎,肝硬化腹水,急、慢性肾炎,疖肿,湿疹。
当归:本品为伞形科植物当归Angelicasinensis(Oliv.)Diels的干燥根。秋末采挖,除去须根及泥沙,待水分稍蒸发后,捆成小把,上棚,用烟火慢慢熏干。【性味】甘、辛,温。【归经】归肝、心、脾经。【功能与主治】补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
鸡血藤:本品为豆科植物密花豆SpatholobussuberectusDunn的干燥藤茎。秋、冬二季采收,除去枝叶,切片,晒干。分布于广东、广西、云南等地。【性味】苦、甘,温。【归经】归肝、肾经。【功能与主治】补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛。
两面针:本品为芸香科植物两面针Zanthoxylumnitidum(Roxb.)DC.的干燥根。全年均可采挖,洗净,切片或段,晒干。【性味】苦、辛,平;有小毒。【归经】归肝、胃经。【功能与主治】行气止痛,活血化瘀,祛风通络。用于跌打损伤、风湿痹痛、胃痛、牙痛,毒蛇咬伤;外治汤火烫伤。
横经席:本品藤黄科胡桐属植物薄叶胡桐CalophyllummembranaceumGardn.etChamp.,以根、叶入药。全年或秋冬采,鲜用或晒干。【性味】微苦,平。【归经】肝;肾经。【功能主治】祛风湿,强筋骨;活血止痛。主治风湿痹证;肾虚腰痛;月经不调;痛经;跌打损伤。
柿叶:本品为柿科植物柿的叶片。【性味】《本草再新》:味苦,性寒,无毒。【归经】专入肺经。【功能主治】止咳定喘;生津止渴;活血止血。治咳喘,肺气胀,消渴及各种内出血。
菥蓂:本品为十字花科植物菥蓂ThlaspiarvenseL.的干燥地上部分。夏季果实成熟时采割,除去杂质,干燥。【性味】苦;甘;微寒。【归经】肝;肾经。【功能主治】清热解毒,利水消肿。主治目赤肿痛;肺痈;肠痈;泄泻;痢疾;白带;产后瘀血腹痛;子宫内膜炎;消化不良;肾炎水肿;肝硬化腹水;痈疮肿毒。
五指毛桃:本品为桑科榕属植物粗叶榕FicussimplicissimaLour.[F.hirtaVahlvar.palmatiloba(Merr.)Chum],以根入药。全年可采,洗净晒干。【性味】甘,微温。【功能主治】健脾补肺,行气化痰,舒筋活络。用于肺结核咳嗽,慢性支气管炎,风湿性关节炎,腰腿疼,脾虚浮肿,病后盗汗,白带;产后无乳;肝硬化腹水;肝炎;跌打损伤。
本发明中药组合物是采用水提或30—70%体积百分浓度的乙醇提取。具体的制备方法如下:
方案一:取全部药材,加水提取2‐3次,每次加水量相当于药材总重量的6‐12倍,每次提取时间为2‐3小时,合并提取液,滤过,滤液浓缩成流浸膏,即得所述活性成分。
方案二:取全部药材,加水提取2‐3次,每次加水量相当于药材总重量的6‐12倍,每次提取时间为2‐3小时,合并提取液,滤过,滤液浓缩至60‐70℃时相对密度为1.05‐1.20的清膏,加入乙醇,使含醇量为40‐70%,静置12‐24小时,滤过,滤液浓缩成流浸膏,即得所述活性成分。
方案三:取全部药材,用30‐70%乙醇回流提取2‐3次,每次乙醇用量为药材总量的4‐10倍,提取时间为1‐3小时,合并提取液,过滤,滤液浓缩成流浸膏,即得所述活性成分。
本发明所述的中药组合物提取物,可以与医药学上可接受的载体配合,制成胶囊剂。
本发明的药学上可接受的载体包括但不限于以下:
稀释剂:淀粉、糖粉、乳糖、糊精、微晶纤维素、无机盐、糖醇类等。
润湿剂与粘合剂:纯化水、乙醇、明胶、聚乙二醇、纤维素衍生物等。
崩解剂:淀粉、羧甲基淀粉钠、纤维素衍生物、交联聚维酮等。
润滑剂:硬脂酸镁、微粉硅胶、滑石粉、聚乙二醇等。
矫味剂:蔗糖、单糖、芳香剂等。
取方案一至方案三所得活性成分之一,干燥成干膏粉,加入胶囊剂常用辅料,按常规生产方法制备得本发明胶囊剂。
上述胶囊剂常用辅料包括稀释剂、润湿剂、粘合剂、崩解剂、润滑剂之一或全部。
本发明中药组合物的用法与用量:本发明的用药量取决于具体剂型、病人的年龄、健康状况等因素。作为指导:用法用量:胶囊剂,每个胶囊含量0.4克生药,每次口服1至3粒,一日3次。
方解:本方证由风热之邪犯表、肺气失和所致。症状表现为发热重、微恶风、头胀痛、有汗、咽喉红肿疼痛(扁桃体炎)、咳嗽、痰粘或黄、鼻塞黄涕、口渴喜饮、舌尖边红、苔薄白微黄。治法应以辛凉解表为主。方中苦玄参、地胆草性味苦寒,清热解毒,消肿止痛共为君药,菥蓂甘苦微寒,清热解毒,利水消肿,为臣药,佐以两面针、横经席、当归、鸡血藤活血通络止痛,配伍柿叶、五指毛桃,引药入肺经,宣肺补肺。本方实为清补两顾之剂,热清邪除,气津得复,诸症自愈。
本发明技术方案符合中医辨证施治的机理,立足疾病之本源,组方合理科学。与现有技术相比,本发明的有益效果:祛风除痰、宣肺解表、益气固本的功能,并且副作用小,疗效快。
具体实施方式
下面通过实施例进一步说明本发明。应该理解的是,本发明的实施例是用于说明本发明而不是对本发明的限制。根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。
实施例1:
取苦玄参350g、地胆草350g、菥蓂300g、柿叶200g、五指毛桃200g、当归150g、鸡血藤150g、横经席200g、两面针150g。将上述全部药材,加水浸泡60min,提取3次,三次加水量分别为药材总重量的12倍、8倍、6倍,三次提取时间分别为3小时、2小时、1小时,合并提取液,滤过,滤液浓缩成流浸膏后,干燥成干膏粉,加入辅料淀粉、乙醇、糊精、硬脂酸镁,装入胶囊壳、制得胶囊剂。
实施例2:
取苦玄参350g、地胆草350g、菥蓂300g、柿叶200g、五指毛桃200g、当归150g、鸡血藤150g、横经席200g、两面针150g。将上述全部药材,加水浸泡60min,提取3次,三次加水量分别为药材总重量的12倍、8倍、6倍,三次提取时间分别为3小时、2小时、1小时,合并提取液,滤过,滤液浓缩至60‐70℃时相对密度为1.05‐1.20的清膏,加入乙醇,使含醇量为40‐70%,静置12‐24小时,滤过滤液浓缩成流浸膏后,干燥成干膏粉,加入辅料淀粉、乙醇、糊精、硬脂酸镁,装入胶囊壳、制得胶囊剂。
实施例3:
取苦玄参350g、地胆草350g、菥蓂300g、柿叶200g、五指毛桃200g、当归150g、鸡血藤150g、横经席200g、两面针150g。将上述全部药材,用30‐70%乙醇回流提取2次,每次乙醇用量分别为药材总量的10倍、5倍,两次提取时间分别为3小时、2小时,合并提取液,过滤,滤液浓缩成流浸膏,干燥成干膏粉,加入辅料淀粉、乙醇、糊精、硬脂酸镁,装入胶囊壳、制得胶囊剂。
临床疗效观察试验
一、一般资料
240例患者均符合外感风热型感冒的诊断标准,将患者随机分成2组,每组120例;2组在性别、年龄、病程及病情严重程度上差异无显著性。
二、试验药物
本发明实施例1‐3所制备的药物、桑菊银翘散。
三、治疗方法
将240例患者随机分成2组,即:试验1组和试验2组,每组各120例。
试验1组采用实施例1所制备的胶囊剂治疗,口服,一次1粒(0.4g生药/粒),一日3次,早中晚各一次,共治疗3天;
试验2组采用中成药桑菊银翘散治疗;口服,一次1袋(10g),一日3次,早中晚各一次,共治疗3天;
服药期间停服其它相关药物及其它治疗。
四、疗效评定标准
痊愈:感冒症状消失,无并发症。
显效:感冒症状缓解,临床症状明显改善;
无效:感冒症状未好转,或出现并发症。
五、治疗结果
试验组1:120例经上述治疗后痊愈92例(占76.7%),显效23例(占19.4%)无效5例(占3.9%)。总有效率为96.1%。
实验组2:120例经上述治疗后痊愈83例(占69.2%),显效27例(占22.5%)无效9例(占7.5%)。总有效率为92.5%。
典型病例:
男22岁,患风热型感冒,服用本发明中药2天便痊愈。
女28岁,患风热型感冒,使用西药一直没有效果,经人介绍服用本发明中药2天便痊愈。
以上结果说明该中药组合物在治疗风热型感冒症有显著疗效。
讨论:妇炎净为《中华人民共和国药典》2010年版公开的复方,目前市面上的中药复方制剂主要用于湿热蕴结所致的带下病、月经不调、痛经;慢性盆腔炎、附件炎、子宫内膜炎见上述证候者。本发明分析处方中的中药组合物,结合君臣佐使、性味归经的中医理论,调整药材用量,着重开发苦玄参、地胆草清热解毒、消肿止痛的功效,标本兼顾,有效治疗风热型感冒兼咽喉肿痛患者,拓宽原方用药范围,提高用药价值。
Claims (5)
1.一种中药组合物在用于制备外感风热药物方面的新用途,其特征在于该组合物是由如下重量份的原料组成:苦玄参350份、地胆草350份、当归150份、鸡血藤150份、两面针150份、横经席150份、柿叶200份、菥蓂300份、五指毛桃200份。
2.如权利要求1所述的新用途,其特征在于它的活性成分是采用水提或30-70%体积百分浓度的乙醇提取制备而成的。
3.如权利要求2所述的新用途,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为2-3小时,合并提取液,滤过,滤液浓缩成流浸膏,即得所述活性成分。
4.如权利要求2所述的新用途,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,加水提取2-3次,每次加水量相当于药材总重量的6-12倍,每次提取时间为2-3小时,合并提取液,滤过,滤液浓缩至60-70℃时相对密度为1.05-1.20的清膏,加入乙醇,使含醇量为40-70%,静置12-24小时,滤过,滤液浓缩成流浸膏,即得所述活性成分。
5.如权利要求2所述的新用途,其特征在于它的活性成分是通过以下方法制备而成的:取全部药材,用30-70%乙醇回流提取2-3次,每次乙醇用量为药材总量的4-10倍,提取时间为1-3小时,合并提取液,过滤,滤液浓缩成流浸膏,即得所述活性成分。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610098788.3A CN105748697A (zh) | 2016-02-23 | 2016-02-23 | 一种中药组合物在用于制备外感风热药物方面的新用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610098788.3A CN105748697A (zh) | 2016-02-23 | 2016-02-23 | 一种中药组合物在用于制备外感风热药物方面的新用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105748697A true CN105748697A (zh) | 2016-07-13 |
Family
ID=56330290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610098788.3A Pending CN105748697A (zh) | 2016-02-23 | 2016-02-23 | 一种中药组合物在用于制备外感风热药物方面的新用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105748697A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210637A (zh) * | 2018-03-28 | 2018-06-29 | 蒋田英 | 一种治疗感冒的中药组合物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634319A (zh) * | 2004-10-18 | 2005-07-06 | 广西梧州制药(集团)股份有限公司 | 一种治疗妇科疾病的中药复方制剂及其制备方法 |
CN103110738A (zh) * | 2012-12-17 | 2013-05-22 | 广西梧州制药(集团)股份有限公司 | 一种治疗妇科炎症的中药组合物及其制备方法 |
-
2016
- 2016-02-23 CN CN201610098788.3A patent/CN105748697A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634319A (zh) * | 2004-10-18 | 2005-07-06 | 广西梧州制药(集团)股份有限公司 | 一种治疗妇科疾病的中药复方制剂及其制备方法 |
CN103110738A (zh) * | 2012-12-17 | 2013-05-22 | 广西梧州制药(集团)股份有限公司 | 一种治疗妇科炎症的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
甘少坚: "中医药治疗咽喉炎近况", 《右江民族医学院学报》 * |
莫小泉: "妇炎净胶囊治疗慢性咽炎38例", 《广西中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108210637A (zh) * | 2018-03-28 | 2018-06-29 | 蒋田英 | 一种治疗感冒的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN101569739B (zh) | 一种治疗胆囊炎的中药组合物及其制备方法 | |
CN102302673B (zh) | 一种预防和治疗糖尿病肾病的中药复方制剂 | |
CN104398938A (zh) | 一种治疗风热犯肺型大叶性肺炎的中药及制备方法 | |
CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
CN105943963A (zh) | 一种治疗猪肺炎的药物 | |
CN105748697A (zh) | 一种中药组合物在用于制备外感风热药物方面的新用途 | |
CN106267028A (zh) | 一种治疗肺炎的中药组合物及其制备方法 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN105169278A (zh) | 一种保肝利胆的蒲公英口服液及其制备方法 | |
CN103735906A (zh) | 一种治疗干性支气管扩张的中药制剂及其制备方法 | |
CN106511812A (zh) | 一种治疗伤风感冒的药物及其制备方法 | |
CN106166251A (zh) | 一种用于治疗哮喘的中药制剂及其制备方法 | |
CN106309589A (zh) | 一种治疗皮肤瘙痒症的药物及其制备方法 | |
CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 | |
CN105031364A (zh) | 一种防治风火牙痛的制剂及制备方法 | |
CN105456933A (zh) | 一种活血化瘀、通经活络的中药及其制备方法 | |
CN105535435A (zh) | 一种治疗阴虚火旺的中药组合物及其制备方法 | |
CN105169277A (zh) | 一种保肝利胆的栀子口服液及其制备方法 | |
CN104906313A (zh) | 治疗气滞血瘀型职业性慢性铅中毒的药物及制备方法 | |
CN104225094A (zh) | 治疗贝赫切特综合征的中药制剂 | |
CN104606444A (zh) | 一种用于拔牙手术的中药麻醉药物及其制备方法 | |
CN104784567B (zh) | 一种治疗泌尿系感染的药物组合物 | |
CN103768376B (zh) | 一种治疗糖尿病的组合药物及制备方法 | |
CN115944692A (zh) | 一种用于治疗感冒的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |
|
RJ01 | Rejection of invention patent application after publication |